Announcement

Collapse
No announcement yet.

Cancers (Basel) . Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA)

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Cancers (Basel) . Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA)


    Cancers (Basel)


    . 2022 Apr 27;14(9):2191.
    doi: 10.3390/cancers14092191.
    Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA)


    Markus Joerger 1 , Yannis Metaxas 2 , Khalil Zaman 3 , Olivier Michielin 4 , Nicolas Mach 5 , Adrienne Bettini 6 , Andreas M Schmitt 7 , Nathan Cantoni 8 , Clemens B Caspar 9 , Sonja Stettler 10 , Roma Malval 11 , Miklos Pless 12 , Christian Britschgi 13 , Christoph Renner 14 , Dieter Koeberle 15 , Jessica D Schulz 16 , Christoph Kopp 16 , Stefanie Hayoz 16 , Anastasios Stathis 17 , Roger von Moos 18 , Swiss Group for Clinical Cancer Research (SAKK)



    AffiliationsFree article

    Abstract

    Purpose: These are the final results of a national registry on cancer patients with COVID-19 in Switzerland.
    Methods: We collected data on symptomatic COVID-19-infected cancer patients from 23 Swiss sites over a one-year period starting on 1 March 2020. The main objective was to assess the outcome (i.e., mortality, rate of hospitalization, ICU admission) of COVID-19 infection in cancer patients; the main secondary objective was to define prognostic factors.
    Results: From 455 patients included, 205 patients (45%) had non-curative disease, 241 patients (53%) were hospitalized for COVID-19, 213 (47%) required oxygen, 43 (9%) invasive ventilation and 62 (14%) were admitted to the ICU. Death from COVID-19 infection occurred in 98 patients, resulting in a mortality rate of 21.5%. Age ≥65 years versus <65 years (OR 3.14, p = 0.003), non-curative versus curative disease (OR 2.42, p = 0.012), ICU admission (OR 4.45, p < 0.001) and oxygen requirement (OR 20.28, p < 0.001) were independently associated with increased mortality.
    Conclusions: We confirmed high COVID-19 severity and mortality in real-world cancer patients during the first and second wave of the pandemic in a country with a decentralized, high-quality, universal-access health care system. COVID-19-associated mortality was particularly high for those of older age in a non-curative disease setting, requiring oxygen or ICU care.

    Keywords: COVID-19; cancer; cancer treatment; coronavirus; pandemic.

Working...
X